Add Press Release About Us FAQ Login
(CIDM, CLNO, PWRM, ZOOG) Hot Stocks by PennyGovernance.com
  Users Blogs
  Content Syndication
   Architecture
   Art and Entertainment
   Automobile
   Automotive
   Business
   Chemical
   Computer
   Computers
   Consumer
   Design
   Economy
   Education
   Employment And Careers
   Employment Opportunity
   Environment
   Events And Trade Shows
   Events and Tradeshows
   Gaming And Casinos
   Government
   Home And Family
   Industry Specific
   Industry Updates
   IndustrySpecific
   Insurance
   Interviews
   Legal And Law
   Lifestyle
   Machinery
   Maritime
   Medical
   Miscellaneous
   Non-profit
   Opinion and Editorial
   Others
   Politics
   Public Utilities
   Religion
   Science and Research
   Society
   Sports
   Teaching and Learning
   Technology
   Telecom
   Textile
   Trade
   Transportation
   Volunteer
(CIDM, CLNO, PWRM, ZOOG) Hot Stocks by PennyGovernance.com

signup3m

 

Cinedigm Digital Cinema Corp. (Nasdaq:CIDM) announced they have signed 100 exhibitors in their Phase Two digital cinema deployment program. Rogers Cinema (a member of the Cinema Buying Group of NATO) signed Cinedigm's VPF deployment agreement for 45 screens in eight locations, marking the 100th exhibitor to sign on to Cinedigm's Phase Two. Rogers Cinema, whose customers are encouraged to "Enjoy the magic of the movies," is a nearly 40-year-old family company that operates theatres in Wisconsin and Michigan.

Cinedigm Digital Cinema Corp. provides technology solutions, financial services and advice, software services, electronic delivery, and content distribution services to owners and distributors of digital content to movie theatres and other venues. Its Phase I Deployment and Phase II Deployment segments engage in the ownership and licensing of digital systems to theatrical exhibitors.

*****************************************

http://pennyomega.com/img/clno.jpgCleantech Transit Inc (CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).


In a few decades the fossil energy sources like oil and coal we use nowadays will be exhausted.

To avoid this we either must change our lifestyle and the habit of wasting energy or we have to find other ways to get energy without exploiting the earth. One way of doing this is getting energy from biomass. Some advantages of biomass are given below:

" Biomass is very abundant. It can be found on every square meter of the earth as seaweed, trees or dung.
" It is easy to convert to a high energy portable fuel such as alcohol or gas.
" It is cheap in contrast to other energy sources.
" Biomass production can often mean the restoration of waste land (e.g. deforested areas).
" It may also use areas of unused agricultural land and provide jobs in rural communities.
" If it is produced on a renewable basis using biomass energy does not result in a net carbon dioxide increase as plants absorb it when they grow


Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.

Cleantech Transit Inc recently reported the commencement of the final permitting prior to going online at Merced. The Merced project is a 500 Kilowatt biomass-generated power plant that is fully constructed, owned and operated by Phoenix Energy (www.phoenixenergy.net). The Merced project received permission for parallel testing to the grid. This testing process would allow Merced to connect to the grid on its own.


For more information about CLNO, visit www.cleantechtransitinc.com


*****************************************

power3 Power3 Medical Products, Inc., (PWRM)

A woman with cancer in one breast has a greater chance of getting a new cancer in the other breast or in another part of the same breast. This is different from a return of the first cancer (called recurrence).

White women are slightly more likely to get breast cancer than African-American women. But African American women are more likely to die of breast cancer. At least part of the reason seems to be because African-American women have faster growing tumors, but we don't know why this is the case. Asian, Hispanic, and Native-American women have a lower risk of getting and dying from breast cancer.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro(R), a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

BC-SeraPro™ is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients. Power3's statistical model evaluates the quantitative information of the protein biomarkers and automatically assigns a probability score. The probability score indicates to the physician that the patient "has cancer" or is "cancer-free". The score reflects how strongly the patient sample fits the biostatistical model and if the patient should be recommended for further follow-up by the clinician.


For more information please visit http://www.power3medical.com


*****************************************

Zoo Entertainment, Inc. (Nasdaq:ZOOG) a leading developer, publisher and distributor of interactive entertainment software, along with developer Eko Software announced plans to release physics-based puzzle game Storm under its indiePub label in Summer 2011 for Xbox LIVE® Arcade for the Xbox 360® video game and entertainment system from Microsoft, PlayStation® Network and PC. "We are constantly in search of innovative projects for the indiePub label, and as the Community Favorite of our first game development competition, we are proud to be involved with the release of Storm," said Mark Seremet, Zoo CEO. "The unique gameplay elements of Storm are coupled with a serene soundtrack to create an inspired gaming experience that can be enjoyed for hours at a time."

Zoo Entertainment is a developer, publisher and distributor of interactive entertainment software targeted to family-oriented mass-market consumers. With a strong network of leading national mass-market retailers, its casual and value-focused titles span categories including sports, family, racing, game show, strategy, action-adventure, and more. Zoo Entertainment software is developed for all major consoles, handheld gaming devices, PCs, and mobile devices as well online and download game services.

Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 2,000,000 shares of 144 restricted stocks from the company for 12 months of advertisement services for Cleantech Transit, Inc. (CLNO.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

http://pennygovernance.com/img/pennygovernance_buscard.jpg

Terms     |    Privacy     |    Contact us     |    Site Map     |    Links
Sitemap   1 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 
62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 
92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 
122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 
152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 
182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 
212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 
242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 
272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 
302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 
332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 
362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 
392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 
422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 
452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 
482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 
512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 
542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 
572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 
602 603 604 605 606 607 608 609 610 611 612 613 614 
This website disclaims any content found in these news releases or articles. Issuers of news releases or articles are solely responsible for the accuracy of their content. If you have any questions regarding information in these news releases, please contact the issuers of the press releases.
© Copyright @ 2005. All rights Reserved. Use of our service is protected by our Privacy policy and Terms of Service.